https://investor.ironwoodpharma.com/press-releases/press-release-details/2009/Ironwood-And-Forest-To-Present-Additional-Phase-2b-Data-For-Novel-Gastrointestinal-Agent-Linaclotide/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- May 12, 2009